Lin Xia
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
Papers in
- Oncology 18
- Drug Transport and Resistance Mechanisms 4
- CAR-T cell therapy research 4
- Peptidase Inhibition and Analysis 3
- HER2/EGFR in Cancer Research 3
- Co-authors
- Rui Du (8 shared papers)Daiming Fan (8 shared papers)Shiren Sun (4 shared papers)Xiaoting Wu (12 shared papers)Yanglin Pan (2 shared papers)Lina Zhao (2 shared papers)Jie Liu (1 shared paper)Dexin Zhang (1 shared paper)
- Journals
- Cancer Medicine (2 papers)PLoS ONE (2 papers)Current Zoology (1 paper)Medicine (1 paper)Oncogene (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Lin Xia
58 papers receiving 2.6k citations
Lin Xia's Hit Papers
Peers
Comparison fields: 5 of 111
- Cancer Research 911
- Gastroenterology 143
- Oncology 476
- Molecular Biology 1.2k
- Geriatrics and Gerontology 40
Countries citing papers authored by Lin Xia
This map shows the geographic impact of Lin Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Xia more than expected).
Fields of papers citing papers by Lin Xia
This network shows the impact of papers produced by Lin Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Xia. The network helps show where Lin Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells Hit paper breakdown → | 2008 | 622 |
| 2 | 2020 | 216 | |
| 3 | 2012 | 168 | |
| 4 | 2012 | 151 | |
| 5 | 2019 | 113 | |
| 6 | 2013 | 112 | |
| 7 | 2014 | 110 | |
| 8 | 2014 | 103 | |
| 9 | 2019 | 79 | |
| 10 | 2020 | 76 | |
| 11 | 2010 | 58 | |
| 12 | 2021 | 55 | |
| 13 | 2009 | 50 | |
| 14 | 2021 | 44 | |
| 15 | 2009 | 42 | |
| 16 | 2019 | 38 | |
| 17 | 2013 | 36 | |
| 18 | 2015 | 36 | |
| 19 | 2012 | 35 | |
| 20 | 2015 | 35 |
About Lin Xia
Lin Xia is a scholar working on Molecular Biology, Oncology, Cancer Research, Genetics and Surgery, having authored 63 papers that have together received 2.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Gastrointestinal Tumor Research and Treatment (5 papers), Drug Transport and Resistance Mechanisms (4 papers), CAR-T cell therapy research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Immunotherapy and Immune Responses (3 papers), Peptidase Inhibition and Analysis (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Cancer Research (911 citations), Gastroenterology (143 citations), Oncology (476 citations), Molecular Biology (1.2k citations) and Geriatrics and Gerontology (40 citations). Lin Xia has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Rui Du, Daiming Fan, Shiren Sun, Xiaoting Wu, Yanglin Pan, Lina Zhao, Jie Liu, Dexin Zhang, Liu Hong and Yong Wang. Their work appears in journals such as Cancer Medicine, PLoS ONE, Current Zoology, Medicine and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.